Signature Therapeutics' Series B Round

Signature Therapeutics raised a round of funding on August 20, 2007. Investors include Hospira.

Signature Therapeutics, formerly PharmacoFore, is a biopharmaceutical company focused on creating medicines to improve upon the therapeutic utility of existing drugs, enhance patient care, and prevent…

Articles about Signature Therapeutics' Series B Round: